Halozyme Therapeutics shares owned by Qsemble Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Qsemble Capital Management
from 13F filings
Historical chart of Qsemble Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Qsemble Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Qsemble Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $974k | 15k | 64.63 |
| 2025-09-30 | $2.0M | 28k | 73.34 |
| 2024-12-31 | $210k | 4.4k | 47.81 |
More positions owned by Qsemble Capital Management
View all positions for Qsemble Capital Management